NET PROFIT (x1000 DKK)
EMPLOYEES
Molymedic AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-11
|
-8
|
-5 |
| EBITDA |
-11
|
-8
|
-5 |
| Total assets |
147
|
85
|
89 |
| Current assets |
147
|
85
|
89 |
| Current liabilities |
94
|
17
|
13 |
| Equity capital |
54
|
68
|
76 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
36.7%
|
80.0%
|
85.4% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-7.5%
|
-9.4%
|
-5.6% |
| Current ratio |
156.4%
|
500%
|
684.6% |
| Return on equity (ROE) |
-20.4%
|
-11.8%
|
-6.6% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.